Amicus Therapeutics Inc.

NASDAQ: FOLD · Real-Time Price · USD
7.40
0.28 (3.93%)
At close: Aug 15, 2025, 3:59 PM
7.41
0.13%
After-hours: Aug 15, 2025, 07:55 PM EDT

Amicus Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-29.37M -56.11M -104.69M -119.54M -147.07M -151.58M -173.61M -185.31M -204.24M -236.57M -263.98M -280.99M -270.06M -250.46M -238.58M -252.3M -253.57M
Depreciation & Amortization
8.23M 8.55M 8.69M 8.75M 8.77M 7.87M 7M 6.06M 5.19M 5.34M 5.55M 5.78M 6.02M 6.21M 7.24M 8.21M 8.69M
Stock-Based Compensation
79.27M 84.91M 83.78M 81.61M 81.99M 86.08M 86.61M 84.87M 80.75M 76.51M 71.79M 68.86M 68.14M 57.84M 56.17M 60.24M 56.91M
Other Working Capital
12.1M 11.06M 33.83M 3.8M -31.68M -24.53M -30.31M -18.44M -3.47M -3.02M -20.66M -12.95M -14.23M -10.04M 451K -2.46M 1.81M
Other Non-Cash Items
-4.48M 52.88M 93.62M 136.05M 91.56M 38.57M 454K 14.88M 22.56M 22.5M 7.38M 3.88M 4.77M -944K 15.51M 13.42M 12.77M
Deferred Income Tax
n/a 4.84M -23.4M -20.28M -197K -9.97M 18.28M 15.33M -4.75M 191K 216K 216K 605K 3.45M 3.26M 2.35M -3.09M
Change in Working Capital
-15.41M -43.74M 696K -43.27M -59.22M -40.05M -92.06M -62.43M -31.18M -39.88M 17.39M 28.53M 2.08M -18.59M -25.39M -32.03M -19.41M
Operating Cash Flow
3.56M -33.89M -26.52M -41.89M -80.72M -69.09M -153.32M -126.6M -126.33M -166.57M -156.32M -168.39M -188.45M -202.49M -181.8M -200.11M -197.7M
Capital Expenditures
-1.95M -3.55M -5M -6.21M -7.31M -7.44M -8.39M -6.68M -4.84M -3.77M -2.85M -3.88M -3.89M -3.88M -3.19M -2.58M -3.29M
Cash Acquisitions
n/a n/a 22.23M 23.79M 25.99M 25.99M 7.18M 5.48M 3.27M 3.27M 1.62M 2.65M 3.02M 3.88M 3.19M 2.58M 3.29M
Purchase of Investments
-124.04M -114.79M -117.4M -129.14M -104.53M -91.72M -196.54M -181.37M -210.76M -243.25M -247.84M -294.47M -314.39M -341.4M -297.23M -465.43M -429.34M
Sales Maturities Of Investments
85.03M 117.78M 118.27M 132.71M 181.19M 197.23M 256.83M 278.71M 282.54M 335.93M 341.62M 349.34M 368.69M 424.04M 424.49M 403.45M 412.37M
Other Investing Acitivies
-4.36M 4.99M -17.24M -15.54M -16.64M -25.99M -67.79M -66.09M -37.24M 21.84M 84.11M 83.08M 56.07M -3.88M -3.19M -2.58M -3.29M
Investing Cash Flow
-40.96M -560K -4.13M -2.63M 69.35M 98.06M 55.32M 94.07M 70.36M 92.32M 90.93M 50.99M 50.41M 78.76M 124.07M -64.56M -20.26M
Debt Repayment
-70K -97K -20.93M -20.98M -20.97M -20.96M -273K -293K -291K -283K -111K -131K -131K -479K -478K 230.25M 230.26M
Common Stock Repurchased
n/a -16.72M -16.72M -16.72M -16.72M n/a -371K -2.21M -2.5M -11.49M -11.43M -9.85M 4.63M -571K -950K -1.93M -16.68M
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-12.78M -14.35M -15.82M -13.73M -13.42M -10.3M -8.81M -10.41M -9.2M 954K -1.75M 199.94M 201.48M 210.68M 234.2M 41.07M 42.92M
Financial Cash Flow
6.73M 5.12M 12.23M 31.66M 56.19M 61.68M 54.02M 15.85M -7.13M -7.46M -8.12M 193.55M 195.09M 212.07M 233.72M 271.32M 273.17M
Net Cash Flow
-28.05M -33.3M -29.52M -2.05M 47.73M 96.83M -15.26M -25.53M -72.84M -96.34M -107.54M 60.07M 49.77M 83.29M 175.65M 12.53M 62.16M
Free Cash Flow
1.61M -37.44M -31.51M -48.1M -88.03M -76.53M -161.71M -133.28M -131.17M -170.34M -159.17M -172.27M -192.34M -206.38M -184.99M -202.69M -200.99M